ARF4-mediated Retrograde Trafficking Drives Chemoresistance in Glioblastoma
Budhiraja, S.; Baisiwala, S.; Perrault, E.; Cho, S.; Nandoliya, K.; Dara, G.; Zolp, A.; Chen, L.; Dmello, C.; Park, C.; Sonabend, A.; Ahmed, A.
Show abstract
Glioblastoma (GBM) is the most common type of adult malignant brain tumor, with a median survival of only 21 months. This is partly due to the high rate of resistance to conventional therapy, including temozolomide (TMZ), leading to recurrence rates close to 100%. It still remains unknown what drives the development of this resistance. To identify the unknown genes driving the development of this resistance, we performed a genome-wide CRISPR knockout screen comparing a DMSO-treated population with a TMZ-treated population over 14 days. We identified 4 previously unstudied genes - ARF4, PLAA, SPTLC1, and PIGK - that showed significant elevations in expression in recurrent tumors in patient datasets, along with significant survival benefits corresponding to low gene expression. Further investigation of ARF4, known to be involved in retrograde trafficking, allowed us to identify a mechanism of resistance that is mediated by increased retrograde transport of EGFR into the nucleus. Ultimately, our CRISPR-Cas9 screen has identified a promising therapeutic target, ARF4, which may drive GBMs high resistance to chemotherapy.
Matching journals
The top 10 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- EMP3 sustains oncogenic EGFR/CDK2 signaling by restricting receptor degradation in glioblastoma 96%
- Capture at the single cell level of metabolic modules distinguishing aggressive and indolent glioblastoma cells 95%
- Cellular Reprogramming of H3K27M Pediatric High-Grade Glioma to Neuron-like State 95%
Similar papers in this journal
Similar papers in this journal
- miR-644a is a tumor cell-intrinsic mediator of sex bias in glioblastoma 95%
- Combined inhibition of SHP2 overcomes adaptive resistance to type 1 BRAF inhibitors in BRAF V600E-driven high-grade glioma 94%
- Tumor Edge-to-Core Transition Promotes Malignancy in Primary-to-Recurrent Glioblastoma Progression in a PLAGL1/CD109-mediated mechanism 93%
Similar papers in this journal
- LNX1 Modulates Notch1 Signaling to Promote Expansion of the Glioma Stem Cell Population During Temozolomide Therapy in Glioblastoma 97%
- Tyrosyl-DNA phosphodiesterase 1 and topoisomerase I activities as predictive indicators for Glioblastoma susceptibility to genotoxic agents 95%
- Profiling anti-apoptotic protein BCL-xL expression in U-87 MG glioblastoma cells and patient-derived tumorspheres 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.